| Friday, Mar 1 | 1530-1620 | Clinical Trials By Centre – Ojectives: status, barriers, needs by centre | Dr. Bernie Eigle | |
| 1530-1540 | Dr. Christian Kollmannsberger for Vancouver | |||
| 1540-1550 | Dr. Joanna Vergidis for Victoria | |||
| 1550-1600 | Dr. Daygen Finch for Kelowna | |||
| 1600-1610 | Dr. Jenny Ko for Abbotsford | |||
| 1610-1620 | Discussion | |||
| 1620-1640 | Status Update on GU drug access/funding (prostate-abiraterone in the mCSPC setting, apalutamide in the CRPC MO space, double IO for mRCC, IO for metastatic bladder | Dr. Helen Anderson | Dr. Christian Kollmannsberger | |
| 1640-1650 | Update on status of guidelines | Dr. Joanna Vergidis | ||
| 1650-1710 | Challenges of Community Oncology | Dr. Simon Yu | Dr. Edward Hardy | |
| 1710-1800 | Biobank program | Dr. Kim Chi | ||
| 1710-1730 | Objectives-Updates and interesting findings | Dr. A. Wyatt | ||
| 1730-1750 | Objectives-MicroRNA results in testes cancer | Dr. Lucia Nappi | ||
| 1750-1800 | Closing Statements and Topics for Next Year | Dr. Joanna Vergidis |